Table 2 |
|||
|
Baseline patient characteristics (Differences between groups by Whitney-Mann test, Dichotomized data were analyzed by the Chi2-Pearson-Test) |
|||
| echo-guided CRT group |
controls |
p |
|
|
|
|||
| n = |
16 |
38 |
|
|
|
|||
| % ischemic cardiomyopathy (ICMP) |
37.5 (n = 5) |
21.1 (n = 8) |
0.49 |
|
|
|||
| Age [years] |
67.1 (± 9.9) |
63.6 (± 10.8) |
0.79 |
|
|
|||
| male % |
93.8 (n = 15) |
68.4 (n = 26) |
0.04 |
|
|
|||
| QRS width [mm] at baseline |
166 (± 13) |
165 (± 18) |
0.48 |
|
|
|||
| Follow-up-interval [months] |
6.7 (± 7.2) |
9.4 (± 3.0) |
< 0.001 |
|
|
|||
| LVEF [%] |
23.1 (± 6.7) |
24.5 (± 7.4) |
0.75 |
|
|
|||
| LV-EDV [ml] |
259.1 (± 111.2) |
262.0 (± 104.8) |
0.98 |
|
|
|||
| LV-ESV [ml] |
199.04 (± 89.4) |
204.3 (± 90.8) |
0.38 |
|
|
|||
| % responder according to reduction of LVESV/increase in EF |
13/16 = 81.2% |
18/38 = 47.4% |
0.04 |
Knebel et al. Cardiovascular Ultrasound 2008 6:58 doi:10.1186/1476-7120-6-58 |
|||
